WINNERS & LOSERS: GSK falls after Nuvalent buy; Molten Ventures jumps
9th Jun 2026 10:34
(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Tuesday. Read More
(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Tuesday. Read More
Silver Bullet Data Services Group PLC - London-based marketing services provider - Calls general meeting for June 25 to ask shareholders to approve its de-listing from the AIM market in London after just five years as a public company. Silver Bullet listed on AIM in June 2021 at 257 pence per share, but its shares have plunged since, losing a further 64% after Tuesday's announcement. Read More
(Alliance News) - Keller Group PLC on Tuesday said it has been awarded a contract variation order relating to the reconstruction of the I-40 highway in the US. Read More
(Alliance News) - Fidelity China Special Situations PLC on Tuesday said the long-term opportunity in China remains "compelling" as it reported an increase in full-year net asset value per share. Read More
(Alliance News) - Molten Ventures PLC and Seraphim Space Investment Trust PLC on Tuesday saw their shares rise after noting a successful fundraise by ICEYE Oy, in which both companies hold interest. Read More
(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More
(Alliance News) - Oxford Instruments PLC on Tuesday said it remains confident in its mid-term goals as it reported mixed annual results. Read More
(Alliance News) - Stock prices in London opened mixed on Tuesday, as the FTSE 100 fell after GSK agreed to buy US-based cancer drug developer Nuvalent for USD10.6 billion. Read More
(Alliance News) - MJ Gleeson PLC on Tuesday said that three land sales, representing more than half of its expected plot sales in the current financial year are being delayed and won't complete until the following year. Read More
(Alliance News) - GSK PLC on Tuesday said it has agreed to US-based cancer drug developer Nuvalent Inc for USD10.6 billion. Read More
(Alliance News) - Bellway PLC on Tuesday backed full-year profit guidance but noted the outlook beyond the current financial year remains uncertain, while customer demand has moderated in recent weeks. Read More
Relx PLC - London-based provider of business, scientific and legal information - Commences a new share buyback scheme worth GBP200 million, and runs until June 26. This follows the GBP150 million programme completed on Monday, with both forming part of the GBP2.25 billion to be deployed on buybacks, as initially reported back in February. Says ABN AMRO Bank NV will manage the programme, adding that the purpose of the scheme is to lower its share capital. Read More
(Alliance News) - AstraZeneca PLC on Monday announced positive results from the Vista and Solstice phase IIb trials of elecoglipron, an oral small molecule GLP-1 receptor agonist. Read More
(Alliance News) - GSK agrees to buy US cancer treatment firm Nuvalent for USD10.6 billion, AstraZeneca advances its own weight-loss treatment while Bellway reports an "increasingly challenging" housing market. Read More
Jubilee Metals Group PLC - London-based metal processing company operating in Zambia - Says run-of-mine deliveries from its Molefe copper mine in Zambia to its Sable refinery in that country have re-started. This follows the expansion of pit two at Molefe mine. Jubilee says Molefe mine remains on track to increase ore deliveries to about 6,000 tonnes this month, increasing to around 8,500 tonnes by August, and targeting steady-state of 10,000 tonnes per month delivered to Sable plant by October. Read More